Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Hearing Loss · Metastatic Malignant Germ Cell Tumor · Metastatic Malignant Nongerminomatous Germ Cell Tumor · Metastatic Malignant Testicular Non-Seminomatous Germ Cell Tumor · Metastatic Testicular Seminoma · Stage II Testicular Cancer AJCC v8 · Stage III Testicular Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Medical Center, Duarte, California, United States
Contact: Principal Investigator (Alex Chehrazi-Raffle)
Study leads
Alex Chehrazi-Raffle
Principal Investigator
City of Hope Medical Center